Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure

Hiroshi Murakami, Jun Li Liu, Irving H Zucker

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart failure. Accordingly, we evaluated the baroreflex control of heart rate (HR) in conscious, chronically instrumented rabbits in the normal state and after the establishment of heart failure. Heart failure was induced by rapid ventricular pacing at a rate of 360-380 beats/min for an average of 14.5 ± 1.4 days. The data were compared with normal rabbits instrumented in a similar fashion. Baroreflex curves were generated by inflation of implanted hydraulic occluders on the vena cava and aortic arch or by administration of phenylephrine and sodium nitroprusside. Experiments were carried out before and after intravenous administration of the AT1 antagonist L-158,809. Rabbits with heart failure exhibited significantly lower arterial pressure (81 ± 3 vs. 69 ± 4 mmHg, P < 0.05), elevated resting HR (230 ± 5 vs. 260 ± 10 beats/min, P < 0.05), and elevated left atrial pressure (3.6 ± 0.7 vs. 13.1 ± 0.7 mmHg, P < 0.05). ANG II blockade had little effect on resting or baroreflex parameters in normal rabbits. However, in rabbits with heart failure, L-158,809 enhanced baroreflex sensitivity (2.7 ± 0.5 vs. 4.7 ± 0.8 beats · min-1 · mmHg- 1; p < 0.05), primarily by increasing the minimum HR evoked during baroreceptor activation. β1-Blockade had no effect on any baroreflex parameter after L-158,809 in rabbits with heart failure. However, L-158,809 significantly reduced the minimum HR after pretreatment with atropine in rabbits with heart failure. These data suggest that ANG II plays a role in modulation of cardiac sympathetic tone in this model of heart failure and may be responsible for the depressed baroreflex sensitivity observed in heart failure.

Original languageEnglish (US)
Pages (from-to)R303-R309
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume271
Issue number1 40-1
StatePublished - Jul 1 1996

Fingerprint

Baroreflex
Heart Failure
Heart Rate
Rabbits
Angiotensin II
Venae Cavae
Pressoreceptors
Atrial Pressure
Economic Inflation
Nitroprusside
Phenylephrine
Renin-Angiotensin System
Thoracic Aorta
Atropine
Intravenous Administration
Arterial Pressure

Keywords

  • arterial pressure
  • sympathetic nerve activity

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure. / Murakami, Hiroshi; Liu, Jun Li; Zucker, Irving H.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 271, No. 1 40-1, 01.07.1996, p. R303-R309.

Research output: Contribution to journalArticle

@article{3dafa12c0cfa4fb09a4ef69c211f55b7,
title = "Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure",
abstract = "Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart failure. Accordingly, we evaluated the baroreflex control of heart rate (HR) in conscious, chronically instrumented rabbits in the normal state and after the establishment of heart failure. Heart failure was induced by rapid ventricular pacing at a rate of 360-380 beats/min for an average of 14.5 ± 1.4 days. The data were compared with normal rabbits instrumented in a similar fashion. Baroreflex curves were generated by inflation of implanted hydraulic occluders on the vena cava and aortic arch or by administration of phenylephrine and sodium nitroprusside. Experiments were carried out before and after intravenous administration of the AT1 antagonist L-158,809. Rabbits with heart failure exhibited significantly lower arterial pressure (81 ± 3 vs. 69 ± 4 mmHg, P < 0.05), elevated resting HR (230 ± 5 vs. 260 ± 10 beats/min, P < 0.05), and elevated left atrial pressure (3.6 ± 0.7 vs. 13.1 ± 0.7 mmHg, P < 0.05). ANG II blockade had little effect on resting or baroreflex parameters in normal rabbits. However, in rabbits with heart failure, L-158,809 enhanced baroreflex sensitivity (2.7 ± 0.5 vs. 4.7 ± 0.8 beats · min-1 · mmHg- 1; p < 0.05), primarily by increasing the minimum HR evoked during baroreceptor activation. β1-Blockade had no effect on any baroreflex parameter after L-158,809 in rabbits with heart failure. However, L-158,809 significantly reduced the minimum HR after pretreatment with atropine in rabbits with heart failure. These data suggest that ANG II plays a role in modulation of cardiac sympathetic tone in this model of heart failure and may be responsible for the depressed baroreflex sensitivity observed in heart failure.",
keywords = "arterial pressure, sympathetic nerve activity",
author = "Hiroshi Murakami and Liu, {Jun Li} and Zucker, {Irving H}",
year = "1996",
month = "7",
day = "1",
language = "English (US)",
volume = "271",
pages = "R303--R309",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 40-1",

}

TY - JOUR

T1 - Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure

AU - Murakami, Hiroshi

AU - Liu, Jun Li

AU - Zucker, Irving H

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart failure. Accordingly, we evaluated the baroreflex control of heart rate (HR) in conscious, chronically instrumented rabbits in the normal state and after the establishment of heart failure. Heart failure was induced by rapid ventricular pacing at a rate of 360-380 beats/min for an average of 14.5 ± 1.4 days. The data were compared with normal rabbits instrumented in a similar fashion. Baroreflex curves were generated by inflation of implanted hydraulic occluders on the vena cava and aortic arch or by administration of phenylephrine and sodium nitroprusside. Experiments were carried out before and after intravenous administration of the AT1 antagonist L-158,809. Rabbits with heart failure exhibited significantly lower arterial pressure (81 ± 3 vs. 69 ± 4 mmHg, P < 0.05), elevated resting HR (230 ± 5 vs. 260 ± 10 beats/min, P < 0.05), and elevated left atrial pressure (3.6 ± 0.7 vs. 13.1 ± 0.7 mmHg, P < 0.05). ANG II blockade had little effect on resting or baroreflex parameters in normal rabbits. However, in rabbits with heart failure, L-158,809 enhanced baroreflex sensitivity (2.7 ± 0.5 vs. 4.7 ± 0.8 beats · min-1 · mmHg- 1; p < 0.05), primarily by increasing the minimum HR evoked during baroreceptor activation. β1-Blockade had no effect on any baroreflex parameter after L-158,809 in rabbits with heart failure. However, L-158,809 significantly reduced the minimum HR after pretreatment with atropine in rabbits with heart failure. These data suggest that ANG II plays a role in modulation of cardiac sympathetic tone in this model of heart failure and may be responsible for the depressed baroreflex sensitivity observed in heart failure.

AB - Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart failure. Accordingly, we evaluated the baroreflex control of heart rate (HR) in conscious, chronically instrumented rabbits in the normal state and after the establishment of heart failure. Heart failure was induced by rapid ventricular pacing at a rate of 360-380 beats/min for an average of 14.5 ± 1.4 days. The data were compared with normal rabbits instrumented in a similar fashion. Baroreflex curves were generated by inflation of implanted hydraulic occluders on the vena cava and aortic arch or by administration of phenylephrine and sodium nitroprusside. Experiments were carried out before and after intravenous administration of the AT1 antagonist L-158,809. Rabbits with heart failure exhibited significantly lower arterial pressure (81 ± 3 vs. 69 ± 4 mmHg, P < 0.05), elevated resting HR (230 ± 5 vs. 260 ± 10 beats/min, P < 0.05), and elevated left atrial pressure (3.6 ± 0.7 vs. 13.1 ± 0.7 mmHg, P < 0.05). ANG II blockade had little effect on resting or baroreflex parameters in normal rabbits. However, in rabbits with heart failure, L-158,809 enhanced baroreflex sensitivity (2.7 ± 0.5 vs. 4.7 ± 0.8 beats · min-1 · mmHg- 1; p < 0.05), primarily by increasing the minimum HR evoked during baroreceptor activation. β1-Blockade had no effect on any baroreflex parameter after L-158,809 in rabbits with heart failure. However, L-158,809 significantly reduced the minimum HR after pretreatment with atropine in rabbits with heart failure. These data suggest that ANG II plays a role in modulation of cardiac sympathetic tone in this model of heart failure and may be responsible for the depressed baroreflex sensitivity observed in heart failure.

KW - arterial pressure

KW - sympathetic nerve activity

UR - http://www.scopus.com/inward/record.url?scp=0030188293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030188293&partnerID=8YFLogxK

M3 - Article

C2 - 8760234

AN - SCOPUS:0030188293

VL - 271

SP - R303-R309

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 40-1

ER -